Skip to content
World edition
Analyst Newspaper
Technology · Multi-perspective analysis

Anthropic Says Its Claude AI Helped Discover Novel Enzyme System

Anthropic says its Claude AI system helped identify a new CRISPR-like enzyme, a discovery outlets across regions have reported with differing levels of technical and safety-related detail.

Analysis deskEditor Andersson Iyke
6 outlets, 4 regions

What happened

Anthropic announced that its Claude AI model helped discover a novel enzyme system, describing it as CRISPR-like.1356

According to Anthropic, Claude analyzed large DNA databases and identified an unusual system built around a reverse transcriptase enzyme, which copies RNA into DNA.3

The Straits Times reported that roughly 950 Claude-powered software agents searched a DNA sequence database for 21 hours as part of the process.4

TechCrunch noted that Anthropic has kept humans in the loop and has not let Claude operate unsupervised in its biology lab.2

What's agreed

Reported consistently by outlets in more than one region.

  • Anthropic announced that its Claude AI model helped discover a novel, previously unknown enzyme system.1356
  • The discovered system is described as CRISPR-like and centered on an unusual enzyme built around a reverse transcriptase, which copies RNA into DNA.13

Where accounts differ

Each account is attributed to who makes it. We do not judge between them.

Potential applications of the discovery

Malay Mail

Reports that the newly discovered enzyme system may enable new gene editing applications.5

How it's framed

What each perspective puts first, based on headlines and summaries.

PerspectiveHow it readsWhat it puts first
Middle East state-controlled outletMiddle East & TurkeyFrames the discovery within the broader context of global anxieties about AI safety and catastrophic risk, rather than focusing on technical biology details.1AI safety debate, catastrophic risks framing
US technology pressNorth AmericaFocuses on Anthropic's operational safeguards, emphasizing that humans remain in control of the AI in its biology lab rather than on the scientific discovery itself.2human oversight, AI safety practices
Southeast Asian privately owned and state-controlled outletsSoutheast AsiaProvide more granular technical detail on the discovery process, including the number of AI agents deployed and time spent searching genetic databases, alongside potential gene-editing applications.456scale of AI search, gene-editing potential, technical process
South Asian syndicated coverageSouth AsiaReports the core scientific claim about the reverse transcriptase enzyme system with minimal additional framing, reflecting syndicated wire-style coverage.3enzyme mechanism, DNA database analysis

What the coverage leaves out

  • None of the outlets reviewed reported independent scientific verification or peer review of the discovery.
  • None of the outlets reviewed detailed specific safety protocols beyond general statements about human oversight.
  • None of the outlets reviewed reported reactions from biosecurity experts or gene-editing researchers outside Anthropic.
  • None of the outlets reviewed specified when or whether the enzyme system might be tested or applied in practice.

Why it matters

The announcement comes amid ongoing global debate about how to safeguard against catastrophic risks from advanced AI systems.1

Anthropic has emphasized that it maintains human oversight over Claude's biology lab work rather than allowing the AI to operate unsupervised.2

Sources (6)

Every outlet we drew on, grouped by where it is based. Read the originals for the full reporting.

Get every side of the day's news.

Join the list for our daily briefing, launching soon.